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Case ReportsParacorporeal lung assist device: An innovative surgical strategy for
bridging to lung transplant in an infant with severe pulmonary
hypertension caused by alveolar capillary dysplasiaUmarS.Boston,MD,a JamesFehr,MD,b,cAvihuZ.Gazit,MD,c andPiroozEghtesady,MD,PhD,a St Louis,MoAlveolar capillary dysplasia is a frequently fatal congenital
pulmonary disease during infancy.1 Lung transplantation
(LT) is the only means of survival. We report the case of
an infant with alveolar capillary dysplasia who subse-
quently had development of severe hemodynamic compro-
mise as a result of refractory pulmonary hypertension (PH)
and was successfully bridged to LT with a paracorporeal
lung assist device (PLAD) in a unique configuration.
CLINICAL SUMMARY
The patient was hospitalized at 2 months of age with
hypoxemia. Echocardiography revealed systemic right ven-
tricular pressures consistent with PH, and chest computed
tomographic scan demonstrated diffuse bilateral interstitial
pulmonary fibrosis. Open lung biopsy yielded the diagnosis
of alveolar capillary dysplasia with misalignment of the
pulmonary veins. Subsequently, the child developed severe
hemodynamic compromise from worsening PH despite
maximummedical therapy, including prostacyclin and nitric
oxide. The patient was therefore placed on venoarterial
ECMO through the neck vessels. This rendered the patient
ineligible for LT at our institution, because venoarterial
ECMO is considered a contraindication in light of the poor
outcomes of such patients.2 PLAD was considered to avoid
the potential complications of ECMO, facilitate rehabilita-
tion, and allow active listing for LT. In patients with severe
PH, PLAD requires central cannulation of the pulmonary
artery (PA) and left atrium (LA), with an extracorporeal
oxygenator interposed.3 The patient was supported on
PLAD for 5 days before undergoing successful LT.
DISCUSSION
Incorporation of an oxygenator in a central configura-
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many) or the Quadrox-iD Pediatric Oxygenator
(MAQUET GmbH & Co KG, Rastatt, Germany), allows
adequate oxygenation and ventilation in patients with re-
fractory PH, provided there is normal biventricular func-
tion and no intracardiac shunt. Our decision to transition
pediatric patients with refractory PH from venoarterial
ECMO to PLAD was based on adult experience4 and
lack of alternatives. PLAD provides right ventricular un-
loading, hemodynamic stability, and weaning from ino-
tropes and pulmonary vasodilators. Furthermore, PLAD
potentially allows extubation and physical rehabilitation
before LT. Before this patient, we had transitioned 3 other
children with refractory PH and severe hemodynamic
compromise from venoarterial ECMO to PLAD. To
date, this case represents the only patient who has been
successfully bridged to LT with the PLAD. The previous
major limitation was the inability to cannulate the LA
with a durable cannula. The alternative—a DLP right-
angle single-stage venous cannula (DLP, Medtronic, Inc,
Grand Rapids, Mich)—was unstable and prone to throm-
bosis. Thromboembolism involving the LA cannula was
the cause of mortality and morbidity in all of the previous
patients.
We describe a novel configuration that allowed the use of
Berlin cannulas (Berlin Heart AG, Berlin, Germany) in both
the PA and LA positions. The oxygenator inflow used a
6-mm Berlin cannula anastomosed to the main PA. The
oxygenator outflow was created by anastomosis of a 10-
mm polytetrafluoroethylene tube to the tip of a 6-mmBerlin
cannula. The polytetrafluoroethylene tube was then anasto-
mosed to an existing atrial septal defect through a right at-
riotomy such that oxygenated blood was channeled across
the atrial septal defect from the right atrium to the LA
(Figure 1).
The cannulation configuration described here has a num-
ber of potential advantages relative to direct cannulation of
the LA. This configuration was designed to stabilize the
intracardiac portion of the cannula and to improve the
outflow dynamics by preventing obstruction of the small
LA. Furthermore, the thromboembolic risk may be less
because this configuration avoids a foreign body sitting
within the LA. Five days of support with this configuration
did not result in thromboembolic complications. A limita-
tion of this novel cannulation strategy is that cardiopulmo-
nary bypass has to be used. In addition, the heart has to beery c October 2013
FIGURE 1. Paracorporeal lung assist device cannulation configuration. MPA, Main pulmonary artery; PTFE, polytetrafluoroethylene.
Case Reportsarrested or fibrillated for a short duration while the PTFE
graft is anastomosed to the atrial septal defect. The impact
of cardioplegic arrest was minimal, however, and the child
separated from cardiopulmonary bypass with favorable
hemodynamics and no inotropic support.
Pediatric patients bridged from venoarterial ECMO to LT
have poor outcomes. This is the first case report in the liter-
ature of successfully bridging an infant with severe PH from
venoarterial ECMO to LT by using a PLAD in a novel
configuration. This case report illustrates an alternative
form of durable mechanical pulmonary support as a bridge
to LT for small pediatric patients.The Journal of Thoracic and CaReferences
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